Reviewed, UniProtKB/Swiss-Prot P02652 (APOA2_HUMAN)

Names and origin

Protein names

Recommended name:
    Apolipoprotein A-II
      Short name=Apo-AII
      Short name=ApoA-II
Cleaved into the following chain:
    1- Recommended name:
            Apolipoprotein A-II(1-76)

Gene names

Name:

APOA2

Organism

Homo sapiens (Human) [Complete proteome]

Taxonomic identifier

9606 [NCBI]

Taxonomic lineage

Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo

Protein attributes

Sequence length	100 AA.
Sequence status	Complete.
Sequence processing	The displayed sequence is further processed into a mature form.
Protein existence	Evidence at protein level.

General annotation (Comments)

Function	May stabilize HDL (high density lipoprotein) structure by its association with lipids, and affect the HDL metabolism.
Subunit structure	Homodimer; disulfide-linked. Also forms a disulfide-linked heterodimer with APOD. Interacts with HCV core protein. Interacts with APOA1BP. Ref.14 Ref.15
Subcellular location	Secreted.
Tissue specificity	Plasma; synthesized in the liver and intestine.
Sequence similarities	Belongs to the apolipoprotein A2 family.
Mass spectrometry	Molecular mass is 8701.2 Da from positions 24 - 100. Determined by MALDI. Ref.16 Molecular mass is 8823.4 Da from positions 24 - 100. Determined by MALDI. Cysteinylated ApoA-II. Ref.16 Molecular mass is 17421.3 Da from positions 24 - 100. Determined by MALDI. Homodimer. Ref.16 Molecular mass is 17293.4 Da from positions 24 - 100. Determined by MALDI. Heterodimer with apolipoprotein A-II(1-76). Ref.16 Molecular mass is 8578.3 Da from positions 24 - 99. Determined by MALDI. Ref.16 Molecular mass is 17166.2 Da from positions 24 - 99. Determined by MALDI. Homodimer. Ref.16

Ontologies

Keywords
Biological process	Host-virus interaction Lipid transport Transport
Cellular component	HDL Secreted
Domain	Signal
PTM	Cleavage on pair of basic residues Disulfide bond Pyrrolidone carboxylic acid
Technical term	3D-structure Complete proteome Direct protein sequencing
Gene Ontology (GO)
Biological process	cholesterol efflux Inferred from direct assay. Source: UniProtKB cholesterol homeostasis Inferred from direct assay. Source: UniProtKB diacylglycerol catabolic process Inferred from direct assay. Source: UniProtKB high-density lipoprotein particle assembly Inferred from direct assay. Source: UniProtKB high-density lipoprotein particle clearance Inferred from direct assay. Source: UniProtKB high-density lipoprotein particle remodeling Inferred from direct assay. Source: UniProtKB interspecies interaction between organisms Inferred from electronic annotation. Source: UniProtKB-KW low-density lipoprotein particle remodeling Inferred from direct assay. Source: UniProtKB negative regulation of cholesterol import Inferred from direct assay. Source: UniProtKB negative regulation of cholesterol transporter activity Inferred from direct assay. Source: UniProtKB negative regulation of cytokine secretion during immune response Inferred from direct assay. Source: UniProtKB negative regulation of lipase activity Inferred from direct assay. Source: UniProtKB negative regulation of lipid catabolic process Inferred from direct assay. Source: UniProtKB negative regulation of very-low-density lipoprotein particle remodeling Inferred from direct assay. Source: UniProtKB phosphatidylcholine biosynthetic process Inferred from direct assay. Source: UniProtKB phospholipid catabolic process Inferred from direct assay. Source: UniProtKB phospholipid efflux Inferred from direct assay. Source: UniProtKB positive regulation of cholesterol esterification Inferred from direct assay. Source: UniProtKB positive regulation of interleukin-8 biosynthetic process Inferred from direct assay. Source: UniProtKB positive regulation of lipid catabolic process Inferred from direct assay. Source: UniProtKB protein folding Inferred from direct assay. Source: UniProtKB regulation of protein stability Inferred from direct assay. Source: UniProtKB response to glucose stimulus Inferred from direct assay. Source: UniProtKB reverse cholesterol transport Inferred from direct assay. Source: UniProtKB triglyceride metabolic process Traceable author statement. Source: UniProtKB triglyceride-rich lipoprotein particle remodeling Inferred from direct assay. Source: UniProtKB
Cellular component	chylomicron Inferred from direct assay. Source: UniProtKB endoplasmic reticulum lumen Inferred from Experiment. Source: Reactome spherical high-density lipoprotein particle Inferred from direct assay. Source: UniProtKB very-low-density lipoprotein particle Inferred from direct assay. Source: UniProtKB
Molecular function	apolipoprotein receptor binding Inferred from physical interaction. Source: UniProtKB cholesterol binding Inferred from direct assay. Source: UniProtKB high-density lipoprotein receptor binding Inferred from physical interaction. Source: UniProtKB lipase inhibitor activity Inferred from direct assay. Source: UniProtKB phosphatidylcholine binding Inferred from direct assay. Source: UniProtKB phosphatidylcholine-sterol O-acyltransferase activator activity Inferred from direct assay. Source: UniProtKB protein heterodimerization activity Ref.14 Inferred from physical interaction. Source: UniProtKB protein homodimerization activity Inferred from direct assay. Source: UniProtKB
Complete GO annotation...

Sequence annotation (Features)

Feature key

Position(s)

Length

Description

Graphical view

Feature identifier

Molecule processing

Signal peptide

1 – 18

18

Ref.3

Propeptide

19 – 23

5

PRO_0000002002

Chain

24 – 100

77

Apolipoprotein A-II

PRO_0000002003

Chain

24 – 99

76

Apolipoprotein A-II(1-76)

PRO_0000002004

Amino acid modifications

Modified residue

24

1

Pyrrolidone carboxylic acid Ref.12

Disulfide bond

29

Interchain (with C-136 in APOD); in heterodimeric form Ref.14

Disulfide bond

29

Interchain; in homodimeric form Ref.14 Ref.5

Experimental info

Sequence conflict

96

1

Q → H in CAA28583. Ref.1

Secondary structure

1

.

.

.

.

.

.

.

.

.

.

.

.

.

100

Helix Strand Turn

Details...

Helix

38 – 53

16

Turn

54 – 57

4

Helix

63 – 65

3

Turn

66 – 68

3

Helix

69 – 77

9

Helix

78 – 80

3

Helix

83 – 86

4

Beta strand

89 – 91

3

Sequences

	Sequence		Length	Mass (Da)
	P02652-1 [UniParc]. Last modified August 13, 1987. Version 1. Checksum: 1247868A25EC3AF2	FASTA	100	11,175
	10 20 30 40 50 60 MKLLAATVLL LTICSLEGAL VRRQAKEPCV ESLVSQYFQT VTDYGKDLME KVKSPELQAE 70 80 90 100 AKSYFEKSKE QLTPLIKKAG TELVNFLSYF VELGTQPATQ

References

	« Hide 'large scale' referencesShow 'large scale' references »
[1]	"Isolation and characterisation of a cDNA encoding the precursor for human apolipoprotein AII." Knott T.J., Priestley L.M., Urdea M., Scott J. Biochem. Biophys. Res. Commun. 120:734-740(1984) [PubMed: 6428397] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA].
[2]	"Human apolipoprotein A-II: nucleotide sequence of a cloned cDNA, and localization of its structural gene on human chromosome 1." Moore M.N., Kao F.-T., Tsao Y.-K., Chan L. Biochem. Biophys. Res. Commun. 123:1-7(1984) [PubMed: 6089788] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA].
[3]	"Human apolipoproteins AI, AII, CII and CIII. cDNA sequences and mRNA abundance." Sharpe C.R., Sidoli A., Shelley C.S., Lucero M.A., Shoulders C.C., Baralle F.E. Nucleic Acids Res. 12:3917-3932(1984) [PubMed: 6328445] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA].
[4]	"The human apolipoprotein A-II gene: complete nucleic acid sequence and genomic organization." Lackner K.J., Law S.W., Brewer H.B. Jr. Nucleic Acids Res. 13:4597-4608(1985) [PubMed: 2989800] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA].
[5]	"The human apolipoprotein AII gene: structural organization and sites of expression." Knott T.J., Wallis S.C., Robertson M.E., Priestley L.M., Urdea M., Rall L.B., Scott J. Nucleic Acids Res. 13:6387-6398(1985) [PubMed: 2995928] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA].
[6]	"Molecular cloning and sequence analysis of human apolipoprotein A-II cDNA." Chan L., Moore M.N., Tsao Y.-K. Methods Enzymol. 128:745-752(1986) [PubMed: 3088392] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA].
[7]	"Sequence polymorphism at the human apolipoprotein AII gene (APOA2): unexpected deficit of variation in an African-American sample." Fullerton S.M., Clark A.G., Weiss K.M., Taylor S.L., Stengard J.H., Salomaa V., Boerwinkle E., Nickerson D.A. Hum. Genet. 111:75-87(2002) [PubMed: 12136239] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA].
[8]	"Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. , Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S. Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Liver.
[9]	"Cloning of human full-length CDSs in BD Creator(TM) system donor vector." Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., Phelan M., Farmer A. Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
[10]	"The DNA sequence and biological annotation of human chromosome 1." Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K. , Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H., Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L., Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J., Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J., Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N., Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V., Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J., Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E., Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R. Nature 441:315-321(2006) [PubMed: 16710414] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
[11]	"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Skeletal muscle.
[12]	"Isolation and characterization of the tryptic and cyanogen bromide peptides of apoLp-Gln-II (apoA-II), plasma high density apolipoprotein." Lux S.E., John K.M., Ronan R., Brewer H.B. Jr. J. Biol. Chem. 247:7519-7527(1972) [PubMed: 4344225] [Abstract] Cited for: PROTEIN SEQUENCE OF 24-100.
[13]	"Cell-free translation of human liver apolipoprotein AI and AII mRNA. Processing of primary translation products." Stoffel W., Krueger E., Deutzmann R. Hoppe-Seyler's Z. Physiol. Chem. 364:227-237(1983) [PubMed: 6407957] [Abstract] Cited for: PARTIAL PROTEIN SEQUENCE OF 1-29.
[14]	"Structure of human apolipoprotein D: locations of the intermolecular and intramolecular disulfide links." Yang C.-Y., Gu Z.-W., Blanco-Vaca F., Gaskell S.J., Yang M., Massey J.B., Gotto A.M. Jr., Pownall H.J. Biochemistry 33:12451-12455(1994) [PubMed: 7918467] [Abstract] Cited for: INTERCHAIN DISULFIDE BOND WITH APOD. Tissue: Plasma.
[15]	"Cloning and characterization of a novel apolipoprotein A-I-binding protein, AI-BP, secreted by cells of the kidney proximal tubules in response to HDL or ApoA-I." Ritter M., Buechler C., Boettcher A., Barlage S., Schmitz-Madry A., Orso E., Bared S.M., Schmiedeknecht G., Baehr C.H., Fricker G., Schmitz G. Genomics 79:693-702(2002) [PubMed: 11991719] [Abstract] Cited for: INTERACTION WITH APOA1BP.
[16]	"Novel mass spectrometric immunoassays for the rapid structural characterization of plasma apolipoproteins." Niederkofler E.E., Tubbs K.A., Kiernan U.A., Nedelkov D., Nelson R.W. J. Lipid Res. 44:630-639(2003) [PubMed: 12562854] [Abstract] Cited for: MASS SPECTROMETRY.
[17]	"Structures of apolipoprotein A-II and a lipid-surrogate complex provide insights into apolipoprotein-lipid interactions." Kumar M.S., Carson M., Hussain M.M., Murthy H.M. Biochemistry 41:11681-11691(2002) [PubMed: 12269810] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 24-100.
+	Additional computationally mapped references.

Web resources

SHMPD

The Singapore human mutation and polymorphism database

Cross-references

Sequence databases

EMBLGenBankDDBJ

X04898 Genomic DNA. Translation: CAA28583.1.
X00955 mRNA. Translation: CAA25467.1.
X02905 Genomic DNA. Translation: CAA26665.1.
X02619 Genomic DNA. Translation: CAA26474.1.
M29882 mRNA. Translation: AAA51701.1.
AY100524 Genomic DNA. Translation: AAM49807.1.
AK312034 mRNA. Translation: BAG34971.1.
BT006786 mRNA. Translation: AAP35432.1.
AL590714 Genomic DNA. Translation: CAH72151.1.
BC005282 mRNA. Translation: AAH05282.1.

IPI

IPI00021854.

PIR

LPHUA2. A93586.

RefSeq

NP_001634.1.

UniGene

Hs.237658

3D structure databases

PDBPDBe

Entry	Method	Resolution (Å)	Chain	Positions	PDBsum
1L6L	X-ray	2.30	1/2/3/4/5/6/7/8/A/B/C/D/E/F/G/H/I/J/K/L/M/N/P/Q/S/T/U/V/W/X/Y/Z	24-100	[»]
2OU1	X-ray	2.00	A/B/C/D/E/F/G/H/I/J/K/L	24-100	[»]

ModBase

Search...

Protein-protein interaction databases

STRING

P02652.

2-D gel databases

SWISS-2DPAGE

P02652.

Siena-2DPAGE

P02652.

Proteomic databases

PeptideAtlas

P02652.

PRIDE

P02652.

Genome annotation databases

Ensembl

ENST00000367990; ENSP00000356969; ENSG00000158874; Homo sapiens. [Genome view]

GeneID

336.

KEGG

hsa:336.

UCSC

uc001fzc.1. human.

Organism-specific databases

CTD

336.

GeneCards

GC01M159458.

HGNC

HGNC:601. APOA2.

MIM

107670. gene.

Orphanet

85450. Amyloid nephropathy, familial.

PharmGKB

PA24886.

GenAtlas

Search...

Phylogenomic databases

HOGENOM

P02652.

HOVERGEN

P02652.

OMA

KAYFEKT

OrthoDB

EOG9XWJHB

Enzyme and pathway databases

Reactome

REACT_602. Metabolism of lipids and lipoproteins.

Gene expression databases

ArrayExpress

P02652.

Bgee

P02652.

CleanEx

HS_APOA2.

Genevestigator

P02652.

GermOnline

ENSG00000158874. Homo sapiens.

Family and domain databases

InterPro

IPR006801. ApoA-II.
[Graphical view]

PANTHER

PTHR11027. ApoA-II. 1 hit.

Pfam

PF04711. ApoA-II. 1 hit.
[Graphical view]

ProDom

PD010397. ApoA-II. 1 hit.
[Graphical view] [Entries sharing at least one domain]

ProtoNet

Search...

Other Resources

NextBio

1391.

PMAP-CutDB

P02652.

SOURCE

Search...

Entry information

Entry name

APOA2_HUMAN

Accession

Primary (citable) accession number: P02652
Secondary accession number(s): B2R524

Entry history

Integrated into UniProtKB/Swiss-Prot:	July 21, 1986
Last sequence update:	August 13, 1987
Last modified:	November 24, 2009
This is version 126 of the entry and version 1 of the sequence. [Complete history]

Entry status

Reviewed (UniProtKB/Swiss-Prot)

Annotation project

HPI (Human Proteome Initiative)

Disclaimer

Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.